188 related articles for article (PubMed ID: 30817182)
1. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Mediated Downregulation of Apolipoprotein A-I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors.
Shavva VS; Bogomolova AM; Nikitin AA; Dizhe EB; Tanyanskiy DA; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
J Cell Biochem; 2017 Feb; 118(2):382-396. PubMed ID: 27404023
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
5. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage.
Wu CH; Chen CC; Lai CY; Hung TH; Lin CC; Chao M; Chen SF
J Neuroinflammation; 2016 Mar; 13(1):62. PubMed ID: 26968836
[TBL] [Abstract][Full Text] [Related]
6. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
[TBL] [Abstract][Full Text] [Related]
7. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
[TBL] [Abstract][Full Text] [Related]
9. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
[TBL] [Abstract][Full Text] [Related]
10. Propofol inhibits proliferation, migration, and invasion of hepatocellular carcinoma cells by downregulating Twist.
Zheng H; Fu Y; Yang T
J Cell Biochem; 2019 Aug; 120(8):12803-12809. PubMed ID: 30861184
[TBL] [Abstract][Full Text] [Related]
11. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
[TBL] [Abstract][Full Text] [Related]
12. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu YL; Chen HY; Hu ML
J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
[TBL] [Abstract][Full Text] [Related]
13. Activation of LXRα induces lipogenesis in HaCaT cells.
Hong I; Rho HS; Kim DH; Lee MO
Arch Pharm Res; 2010 Sep; 33(9):1443-9. PubMed ID: 20945144
[TBL] [Abstract][Full Text] [Related]
14. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
16. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
17. Isoginkgetin, a potential CDK6 inhibitor, suppresses
Yao J; Tang S; Shi C; Lin Y; Ge L; Chen Q; Ou B; Liu D; Miao Y; Xie Q; Tang X; Fei J; Yang G; Tian J; Zeng X
Autophagy; 2023 Apr; 19(4):1221-1238. PubMed ID: 36048765
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
19. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro.
Zhu Y; Pan Y; Zhang G; Wu Y; Zhong W; Chu C; Qian Y; Zhu G
Biol Pharm Bull; 2018 Jan; 41(1):36-46. PubMed ID: 29093327
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
Gao J; Ding F; Liu Q; Yao Y
Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]